Oral pilocarpine for treatment in patients with xerotic keratoconjunctivitis

Oral pilocarpine for treatment in patients with xerotic keratoconjunctivitis - Oral Pilocarpine for treatment in patients with dry eye

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002200

Enrollment

50

Registered

2009-09-01

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

xerotic conjunctivits

Interventions

Oral pilocarpine

Sponsors

Department of Ophthalmology and Visual neuroscience,The University of Tokushima, School of Medicine

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The people who has the complainment of dryness, watering,eye fatigue. The people who has the abnormality of tear The people who has the keratoconjunctive epithelium disturbance

Exclusion criteria

Exclusion criteria: Diabetic mellitus The people who wear the contact lens The patients who take a therapy of eye drops for glaucoma

Design outcomes

Primary

Measure	Time frame
A complainment of dry eye The tear secretion Break up time of the tear Keratocounjunctive epithlium disturbance	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026